
As of today, inoculations using Astrazeneca's vaccines are put on pause in Denmark as a consequence of an investigation at the European Medicines Agency (EMA) evaluating the potential side effects of the vaccine.
"For cautionary reasons, the [Danish] Ministry of Health has paused Astrazeneca vaccinations following signs of a possible serious side effect in the form of lethal blood clots. Currently, we cannot conclude whether the two things are connected. We're acting early on, and this must be investigated thoroughly," Danish Minister for Health Magnus Heunicke says on Twitter.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Fruergaard leveraging experience from Danish partnerships in key roles in Brussels
Experiences from Danish climate partnerships are among the tools that can be leveraged when Novo Nordisk CEO Lars Fruergaard begins stepping up efforts in the life science sector’s central organs in Brussels. ”I’ve been fired up by the intimacy and shared vision we could see in Denmark,” he tells MedWatch.